ANGPTL4 and hyperlipidemia: Reportedly, liver-specific Akt activation [32], angiopoietin-like protein 4 overexpression [33], and inhibition of phosphatase and tensin homolog [34] improved glucose tolerance, but induced hyperlipidemia and hepatic steatosis in mice.